April 16 (Reuters) - Neuroone Medical Technologies Corp NMTC.O:
NEUROONE MEDICAL TECHNOLOGIES CORP -COMPANY NOW FULLY FUNDED THROUGH AT LEAST FISCAL 2026
NEUROONE MEDICAL TECHNOLOGIES CORP: CONFIRMS NO MATERIAL IMPACT FROM GLOBAL TARIFFS
NEUROONE MEDICAL TECHNOLOGIES CORP: REITERATING OUR FISCAL YEAR 2025 GUIDANCE
Source text: ID:nGNX9Xw4Np
Further company coverage: NMTC.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.